Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $5.49 Million - $7.34 Million
-15,661 Reduced 23.0%
52,429 $24.6 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $3.06 Million - $3.59 Million
9,846 Added 16.9%
68,090 $23.4 Billion
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $6.52 Million - $7.59 Million
20,271 Added 53.38%
58,244 $21.3 Billion
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $2.61 Million - $3.06 Million
9,363 Added 32.73%
37,973 $12.3 Million
Q1 2022

May 17, 2022

SELL
$234.69 - $291.66 $3.34 Million - $4.15 Million
-14,231 Reduced 33.22%
28,610 $8.19 Million
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $4.32 Million - $5.36 Million
-19,193 Reduced 30.94%
42,841 $11.8 Million
Q3 2021

Nov 16, 2021

SELL
$221.6 - $272.71 $2.52 Million - $3.11 Million
-11,389 Reduced 15.51%
62,034 $14.3 Million
Q2 2021

Aug 17, 2021

SELL
$180.55 - $233.54 $2.45 Million - $3.17 Million
-13,579 Reduced 15.61%
73,423 $16.9 Million
Q1 2021

May 18, 2021

BUY
$164.32 - $212.72 $3.93 Million - $5.08 Million
23,889 Added 37.85%
87,002 $16.3 Million
Q4 2020

Feb 17, 2021

BUY
$130.46 - $172.63 $3.52 Million - $4.66 Million
27,014 Added 74.83%
63,113 $10.7 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $2.58 Million - $2.98 Million
-17,622 Reduced 32.8%
36,099 $5.34 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $5.09 Million - $6.12 Million
37,290 Added 226.95%
53,721 $8.82 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $599,773 - $742,349
-5,038 Reduced 23.47%
16,431 $2.28 Million
Q4 2019

Feb 12, 2020

SELL
$106.92 - $132.43 $1.46 Million - $1.8 Million
-13,623 Reduced 38.82%
21,469 $2.82 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $98,780 - $107,448
925 Added 2.71%
35,092 $3.92 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $456,454 - $532,798
-4,120 Reduced 10.76%
34,167 $3.79 Million
Q1 2019

May 16, 2019

SELL
$111.31 - $131.02 $1.21 Million - $1.42 Million
-10,830 Reduced 22.05%
38,287 $4.97 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $5.2 Million - $5.83 Million
49,117 New
49,117 $5.68 Million
Q3 2018

Nov 15, 2018

SELL
$85.86 - $107.31 $5.13 Million - $6.41 Million
-59,748 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $4.52 Million - $5.19 Million
59,748 New
59,748 $5.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kiwi Wealth Investments Limited Partnership Portfolio

Follow Kiwi Wealth Investments Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.